Imaging With [11C]Martinostat in Breast Cancer

Summary

This research study is studying a PET imaging tracer as a possible means of imaging breast cancer. The imaging agent involved in this study is: -\[11C\]Martinostat (called C-eleven-Martinostat)

Timeline

Start

2020-02-01

Primary completion

2020-02-28

Completion

2024-10-31

Outcome

Outcome not reported

Stopped: “Principal investigator left the study institution.”

Drugs

Indications